Race Oncology looks to accelerate clinical development of bisantrene

By Proactive Investors / February 28, 2024 / www.youtube.com / Article Link

Race Oncology Ltd (ASX:RAC) CEO Daniel Tillett joins Jonathan Jackson in the Proactive studio to provide an update on the ...

Recent News

US tariff decision expected to be major copper catalyst

July 07, 2026 / www.canadianminingreport.com

Gold stocks rebound from near lows

July 07, 2026 / www.canadianminingreport.com

Gold stocks decline as metal price drops

June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week

June 22, 2026 / www.canadianminingreport.com

See all >